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ABSTRACT
This thesis is composed of studies that regard the advancement to the Arctic region and
the importance of host-microbe interactions in natural product discovery. Bioactive metabolites
have been reported from a myriad of marine and terrestrial organisms around the world including
plants, insects, sponges, tunicates, bacteria, and fungi among others. Many macroorganisms, of
which the metabolites are found, depend on the symbiotic relationship of microorganisms for
metabolite production. The scope of this work is to investigate secondary metabolism of both
marine and terrestrial organisms from different areas of the world as well as search for the
importance of host-microbe symbiosis on a chemical level.
Chapter 1 comprises a review of bioactive sponge secondary metabolites reported from
Arctic sponge species. Although more tropical and easily accessible waters have been
investigated, other regions including the more dark, cold polar regions, specifically the Arctic,
represent a less explored frontier for secondary metabolite discovery. Additionally, a survey of a
2010 sponge collection in the Aleutian Islands, AK, is displayed and assesses the chemical
potential of sponge species in the area. The description of two small molecule aldehydes with
reported broad spectrum bioactivity from a new species of Guitarra obtained through this
collection is also given.
Chapter 2 discusses the chemical investigation of a new sponge species of the genus
Monanchora from the Aleutian Islands. Different species of Monanchora, including M. pulchra,
have been classified within the region. Through de-replication, members of the class of potent
cytotoxic, antimicrobial compounds known as the monanchocidins were identified from the
ii

sponge. Further investigation of the metabolome and development of bioactivity will continue to
be investigated in the future.
Studies have suggested that the chemical complexity of sponges is dependent upon not
only the sponge itself, but rather an intricate associated microbial community. Chapter 3
presents the results of fermentations of sponge-associated Micromonospora sp. M42, yielding
seven small molecule secondary metabolites, with four belonging to a class of broad spectrum
bioactive molecules known as diketopiperazines. Previous research suggests that these
compounds possess bioactivities that can benefit the sponge in a symbiotic relationship,
including growth promoter and antifouling properties. Screening of the crude extracts revealed
the presence of the diketopiperazines in the sponge. Additionally, a genomic evaluation of the
biosynthetic machinery of M42 was performed. This data was generated in supplement of
previously done work regarding the entire sponge-associated microbiome and previous
confirmation of manzamine production by M42 as well as a series of biotranformation studies
that add insight to the generation of the array of manzamine derivatives found in the sponge.
Chapter 4 discusses the metabolite nicotianamine, a compound found in all higher plant
species that possesses antioxidant and metal-binding properties that can be helpful in use as a
food preservative in replacement of EDTA. Preliminary data into the optimization of the
isolation and quantification of nicotianamine on an analytical scale is presented.
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CHAPTER 1

EXPLORING THE ARCTIC REGION FOR BIOACTIVE SPONGE METABOLITES

Part of this section was published in:
Abbas, SH., Kelly, M., Bowling, J., Sims, J., Waters, A and Hamann, MT. Marine Drugs (2011),
11: 2423-2437.

Marine sponges have provided a vast resource in the search for bioactive secondary
metabolites and potential drug leads. With most research in the area of bioactive sponge
metabolites being conducted in temperate and tropical areas and the strong emergence of a
myriad of disease resistance, it is becoming increasingly important to survey the fauna of remote
regions of the globe for new and replacement drug therapies or compounds with other useful
bioactivities. Porifera of cold water environments, including the deep sea and northern polar
regions in particular, are marginally known in terms of their faunas, and as such are a relatively
untapped resource for scientific discovery. In fact, of all marine natural products described, less
than 3% originate from organisms in polar environments.1 Among the research conducted in
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polar environments, the majority of compounds isolated and characterized have come from the
Antarctic region.1, 2 This article discusses bioactive molecules that have been discovered in the
southern reaches of the Arctic Circle and the particular significance of a recent sponge collection
conducted in the Aleutian Islands, Alaska. The handful of studies that have been completed in
this area are primarily represented by sponges collected in more easily accessible coastal waters
of Alaska and off the coast of Sweden and Norway. A potentially fruitful opportunity for new
bioactive marine secondary metabolites lies within the cold water regions of the earth, where
little, but promising, research has been completed.
Articles addressing cold water bioactive metabolites and the chemical ecology of cold
water sponges, particularly the Antarctic region, have been published by our group and others.1-4
These articles cover some of the compounds listed here and should be consulted for a recording
of cold water marine metabolites from various organisms.4 This work focuses primarily on
bioactive sponge metabolites from Alaska and other more northern Arctic cold water regions.

SECONDARY METABOLITES ISOLATED FROM ARCTIC SPONGES
There are many reasons for the lack of exploration of the metabolites of polar sponges,
but the most obvious are the difficulties associated with the access to polar regions and the harsh
working environments. Several decades ago the misconception was held that, due to the
harshness of the general environment, sponge biodiversity in polar regions would be poor, and
competitive pressure to develop chemical defenses were low or non-existent.1 However, today
we know from work in the Antarctic and revised opinions of Arctic benthos that polar regions
are rich in sponge diversity5-7 with comparable species numbers to southern cold-temperate
regions8 and that polar marine invertebrates, including sponges, possess a high number of
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chemical defenses.9 Despite the suggestions of high polar sponge biodiversity and thus a
potential source for marine drug discovery, less than 100 metabolites from cold water sponges
have been described as of 2010, as compared to thousands from temperate and tropical regions.10
Consequently, extensive sponge surveys in the polar environments for the discovery of new
bioactive molecules have merit. The following information reviews the bioactive compounds that
have been discovered from marine sponges collected in the southern-most limits of the Arctic
Ocean.

Discorhabdin Alkaloids
One of the major groups of compounds that have been found in polar sponges of the
genus Latrunculia (Class Demospongiae, Order Poecilosclerida, Family Latrunculiidae) are the
discorhabdin alkaloids. Many different derivatives of discorhabdins were originally isolated from
Antarctic and New Zealand species of Latrunculia yielding an impressive array of activities.
Discorhabdin C (1) (Figure I.1) was first described in 1986 as isolated from the New Zealand
species L. cf bocagei Ridley and Dendy, 1886, and exhibited potent antitumor bioactivity against
L1210 tumor cells with an ED50 of less than 100 ng/mL.11 Discorhabdin F12 was subsequently
isolated in 1990 from the Antarctic species L. biformis Kirkpatrick, 1907 followed by
discorhabdin G from L. apicalis Ridley and Dendy, 1886.13, 14 Discorhabdin R (2) (Figure I.1)
was isolated in 2000 from an unidentified species of Latrunculia collected from Prydz Bay,
Antarctica, exhibiting activity similar to other discorhabdins encompassing Gram positive and
Gram negative species of bacteria among others.15
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Figure I.1. Discorhabdin C (1) and discorhabdin R (2); members of the discorhabdin alkaloids,
exhibiting a spectrum of bioactivities, isolated in 1986 and 2000, respectively, from New
Zealand and Antarctic sponge species of the genus Latrunculia.11, 15

In 2009, eight members of the same class of discorhabdin alkaloids, including the new
dihydrodiscorhabdin B (3) and discorhabdin Y (4), were isolated from members of Latrunculia
in the Arctic region off the coast of Alaska in the Aleutian Islands (Figure I.2).4 This was the first
report of bioactive compounds from sponges collected in the Alaskan region. The compounds
isolated from this new, undescribed species of Latrunculia, demonstrated anti-HCV,
antimalarial, and antibacterial activities along with two previously described discorhabdins,
dihydrodiscorhabdin C (5) and discorhabdin A (6), showing selective anti-protozoal activity in
vitro.4 From this report, compounds 5 and 6, along with compound 1, had reported IC50 values of
170, 53, and 2800 nM against chloroquine-susceptible Plasmodium falciparum and 130, 53, and
2000 nM against chloroquine-resistant P. falciparum, respectively. Compounds 5 and 6 were
tested in vivo using a murine model for antimalarial activity, however, high levels of toxicity
were observed including weight loss, movement reduction, and dehydration. Regardless of these
in vivo results, the first report of bioactive compounds from an Alaskan sponge being used in an
animal model provides promise for future bioactive molecules from the region. Reports suggest
that the discorhabdin alkaloids have potential due to their varied biological activities, and new
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information on the group and the species they have been isolated from16-19 have been discovered
during the past 25 years.

Figure I.2. Compounds isolated from a new, undescribed species of Latrunculia from the
Aleutian Islands. The compounds listed are dihydrodiscorhabdin B (configuration unassigned)
(3), discorhabdin Y (4), dihydrodiscorhabdin C (5), discorhabdin A (6), discorhabdin E (7),
discorhabdin L (8), and also discorhabdin C (1, Figure I.1).4

Monanchocidins
A group of new polycyclic guanidine containing alkaloids were discovered from
Monanchora pulchra in 2010 and 201120, 21 near Urup Island in the southern Sea of Okhotsk at a
similar latitude to the discorhabdins in Figure I.2. Monanchocidins A–E (9–13) (Figure I.3)
demonstrated apoptosis-inducing activity against HL-60 human leukemia cells at 540, 200, 110,
830, and 650 nM respectively.21
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Figure I.3. Cytotoxic monanchocidins A–E (9–13) isolated from M. pulchra.21

3-Alkylpyridinium Alkaloids
A series of 3-alkylpyridinium alkaloids have been isolated from the Arctic sponge
Haliclona (Rhizoniera) viscosa (Topsent, 1888) (Class Demospongiae, Order Haplosclerida,
Family Chalinidae) with interesting bioactivity including antibacterial, antifungal, cytotoxic, and
feeding deterrent effects.22 Until 2004 Haliclona spp. and related genera had only been described
from more tropical and temperate environments where they are more abundant and diverse in
terms of species. Specimens of H. viscosa were collected in Kongsfjorden, an inlet on the west
coast of Spitsbergen, an island which is part of the Svalbard Archipelago in the Arctic Ocean.
The specimens yielded two compounds elucidated as viscosamine (14) and viscosaline (15)
(Figure I.4), the first acyclic dimeric 3-alkylpyridinium alkaloid isolated from nature.23 Both
compounds exhibit antibacterial activity while viscosaline has been reported as a feeding
deterrent against the amphipod Anonyx nugax and starfish.22
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Figure I.4. Bioactive compounds viscosamine (14) and viscosaline (15) isolated from the Arctic
sponge Haliclona viscosa.23

Diketopiperazines
Two diketopiperazines, barettin (16) (Figure I.5) and 8,9-dihydrobarettin were isolated
from the sponge Geodia barretti Bowerbank, 1858 (Class Demospongiae, Order Astrophorida,
Family Geodiidae) in the North Sea off the coast of Sweden.24 These compounds exhibited
extremely interesting non-toxic bioactivity as an antifouling agent, inhibiting the settlement of
larvae of the barnacle Balanus improvisus and the blue mussel Mytilus edulis when mixed with
surface coatings.

Figure I.5. Barettin (16), isolated from the sponge Geodia barretti collected in the
North Sea.24
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Polymastiamides
Polymastiamide A (17) (Figure I.6), the first reported marine natural product derived
from a steroid and α-amino acid component, was isolated from the Norwegian sponge
Polymastia boletiformis (Lamarck, 1815) (Class Demospongiae, Order Hadromerida, Family
Polymastiidae), and showed in vitro activity against the microorganisms Staph. aureus, Candida
albicans, and Pythium ultimum.25 Conjugates with similar steroid/amino acid constitutions were
subsequently isolated from the same sponge species to give polymastiamides B (18), C (20), D
(21), E (19), and F (22) 24 (Figure I.6).

Figure I.6. Polymastiamide A, B, E (17, 18, 19) and C, D, F (20, 21, 22) isolated from the
Norwegian sponge Polymastia boletiformis.25, 26

Cyclic Peroxides
Another Norwegian sponge, Plakortis simplex Schulze, 1880 (Class Demospongiae,
Order Homosclerophorida, Family Plakinidae), yielded two new cyclic peroxides (23, 24)
(Figure I.7) with 24 showing in vitro IC50 values between 7 and 15 µg/mL for a number of
different solid human tumor cell lines.27
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Figure I.7. Two cyclic peroxides, 23 and 24, isolated from the Norwegian sponge
Plakortis simplex.27

RECENT COLLECTIONS AROUND THE ALEUTIAN ISLANDS, ALASKA
Two recent collection trips were performed in collaboration with the NOAA/AFSC
annual groundfish survey. Collection sites in the summer of 2010 were in the western Aleutian
Islands between Adak Island and Stalemate Bank. The depths of these collections ranged 60–400
m. Specimens were collected by fishing trawl and were sorted by morphology and immediately
frozen at −20 °C. Following the survey samples were shipped frozen for extraction and chemical
analysis.

Taxonomic Overview of the Region
Our understanding of the sponge fauna of the Aleutian Islands and the Alaskan Arctic is
aided by taxonomic literature based on collections principally from the Chukchi and East
Siberian Seas, the Aleutian Island chain and Alaskan coastline to the north, Kamchatka
Peninsula, Kurile Islands, the Sea of Okhotsk to the west, and the Bering Sea to the north.
However, unlike the Antarctic region, few large scale collections and taxonomic studies of the
overall sponge fauna of this region have been produced,28 and many reports are old and in need
of revision. A full review of the species known from the region has not been available, but we

9

know from recent studies29, 30 and collections that the sponge/demosponge fauna, at least, is
diverse and dominated by poecilosclerid taxa.
General literature for the Bering Sea and Alaskan Arctic includes references31-34 for the
southwestern Sea of Okhotsk and reference35 for the northwest Pacific in general. More recently,
Lehnert et al. 28 (and in previous reports), commenced the documentation of a number of deep
and shallow water sponges from the region, many of which were found to be new species.
Taxonomic literature from the Gulf of Alaska and British Columbia to the southeast of the
Aleutians, and to a lesser extent, the coasts of Washington, Oregon, and northern California, are
important resources for any work in the Aleutians and Alaskan Arctic. Lambe,36-38 more recently
Austin,29 and Austin and Ott30 provide the best starting points for any taxonomic work in the
region. Lee et al. 39 on the sponges of California is also particularly relevant.

New Species Found from the Collection
Of the 93 sponge specimens collected during the 2010 voyage, six have been formally
identified and two are new, undescribed species. Five out of the six specimens are in the Order
Poecilosclerida, the most diverse order of demosponges, and typically the most common type of
demosponge found in polar regions.6 The sixth specimen is from the Order Astrophorida, an
order of Demospongiae much less common in polar regions than in temperate regions such as
around New Zealand.6, 8
Of the five poecilosclerid sponges, two were species of Latrunculia (Family
Latrunculiidae); L. oparinae (Samaai and Krasokhin, 2002) and the new species detailed in
reference 4. This genus has presented a major group of compounds, the discorhabdin alkaloids,
with a striking array of activities as detailed above. Research on this important group has focused
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on Antarctic and New Zealand species, but these current explorations are documenting their
existence in the North Pacific and southern Arctic regions.11-15 Prior to this work, L. oparinae
was known only from the Russian Kurile Islands, in the Sea of Okhotsk, between depths of 127
and 238 m. In the Aleutian Islands, the species is quite common where it is found between
depths of 81 and 288 m. The species has a globular shape with tall cylindrical oscules (exhalent
structures), and is light olive to khaki green in life. The new, and as yet, undescribed species
detailed in reference 4 is similar to L. oparinae but differentiated by color in life. It is dark
purple brown, possesses the short flat oscules, and the perfectly hemispherical shape. L. austini
(Samaai, Gibbons and Kelly, 2006) known from the Vancouver Coast of British Columbia,
Canada, and further south, is a relatively shallow water species (20–50 m), grayish brown in life,
spherical in shape, and with broad crater-like areolate porefields that dominate the sponge
surface. Latrunculia velera (Lehnert, Stone and Heimler, 2006) from the Aleutian Islands, is a
dark brown elongate to subglobose sponge with short tiny oscules. The primary feature that
differentiates each of these species is the shape and ornamentation of the family-specific
microsclere, the anisodiscorhabd (Figure I.8). L. occulta (Lehnert, Stone and Heimler, 2006)
also from the Aleutian Islands, is now considered to be a species of the genus Chondrocladia
(Meliiderma) (Order Poecilosclerida, Family Cladorhizidae).40 While these species produce an
array of different compounds, they are difficult to differentiate at the species level other than by
the shape and ornamentation of the family-specific microsclere, the anisodiscorhabd (Figure I.8).
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Figure I.8. Comparison of the morphology and ornamentation of anisodiscorhabd spicules that
distinguish species of Latrunculia in the northern Pacific-Arctic region:
(a) Latrunculia oparinae (Samaai and Krasokhin, 2002); (b) Latrunculia n. sp. (dark purple
brown hemisphere); (c) Latrunculia austini (Samaai, Gibbons and Kelly, 2006);
(d) Latrunculia velera (Lehnert, Stone and Heimler, 2006); (e) Latrunculia occulta (Lehnert,
Stone and Heimler, 2006); Scale bar = 10 µm.

Of the five poecilosclerid sponges, two were species of Monanchora (Family
Crambeidae); M. pulchra (Lambe, 1895), first described from the Aleutian Islands, and a new,
undescribed species, M. n. sp. 1 (yellow fan). There are two additional species of this genus
known from the Aleutian Islands, Eastern Bering Sea, and the Gulf of Alaska; M. alaskensis
(Lambe, 1895) and M. laminachela (Lehnert, Stone, and Heimler, 2006). The key differences
between these four species are in the gross morphology of the sponge, the coloration life, the
length of the skeleton-forming megascleres, and the length and shape of the microscleres (Table
I.1).
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Table I.1. Key differences between species of Monanchora (Order Poecilosclerida, Family
Crambeidae) in the Aleutians-Arctic region.
Monanchora Monanchora n. sp.

Monanchora

Monanchora

pulchra

1 (yellow fan)

alaskensis

laminachela

shape

ramose fan

fan

short flabby

subglobular

color in life

red

yellow

brown

yellow

styles (interior) (µm)

1100

480–510

262

840–1170

styles (dermal) (µm)

176–478

200–250

144

350–395

microscleres 1 (µm)

19

30–35

91

22–25

microscleres 2 (µm)

13

20

32

19–23

The single astrophorid species is Poecillastra rickettsi de Laubenfels, 1930 (Family
Pachastrellidae), first described from the northern Californian coast.

PROCESSING OF COLLECTED ARCTIC SPONGE SAMPLES
Each of the 93 sponge samples were initially processed by extracting 50 g portions (wet)
with ethanol. The resulting extract (5 mg of each sample) was submitted for opportunistic
infections, antimalarial, and anti-hepatitis C virus assays. For more rapid results, each extract
was screened using a disc diffusion assay against Bacillus cereus.
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Disc Diffusion Assay
Extracts were tested with kanamycin used as a positive control. Extracts were applied to
the disc using methanol to give a total of 1 mg of extract on each disc. A total of 100 µg of
kanamycin was applied to the control disc. A bacterial lawn of Bacillus cereus was created by
spreading 250 µL of water containing live cells. The discs were then placed upon the media and
allowed to incubate for 24 hours before examining for zones of inhibition.
In vitro Bioactivity
An initial in vitro screen of 93 crude sponge extracts revealed bioactivity against many
microorganisms associated with opportunistic infections (Figure I.9), indicating a broader than
expected activity against a small sample set of different microorganisms. The extracts were also
screened against Plasmodium falciparum (malaria) and HCV resulting in the identification of
several samples with significant activity.

Figure I.9. The percent of crude extracts of 93 Alaskan sponge samples that yielded significant
activity (greater than 50% inhibition in vitro) against different opportunistic infections (Candida
albicans, Candida glabrata, Candida krusei, Aspergillus fumigatus, Cryptococcus neoformans,
Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus, Escherichia coli,
Pseudomonas aeruginosa), malaria, and hepatitis C virus (HCV)(methods described in reference
4).
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The IC50 values for active sponge extracts ranged from 200 to 5000 ng/mL against the
different opportunistic infections (ciprofloxacin and amphotericin B as controls) and antimalarial
IC50 ranged between 500 and 2200 ng/mL (chloroquine and artemisinin as controls); anti-HCV
IC50 values were not determined. Many of the active samples are currently being examined for
their active components and will be reported in due time. The initial screen for activity combined
with the evidence of interesting taxonomic classification highlights the potential of the polar
region for new bioactive compounds.
CONCLUSIONS
With roughly 70% of the earth covered with ocean, marine sources provide an enormous
source for scientific research and discovery. Numerous collections conducted for over half a
century to collect sponges in particular for their bioactive secondary metabolites have been
carried out in many cold temperate, temperate, tropical, and subtropical locations across the
Atlantic and Pacific Oceans and in other parts of the globe. These efforts and their results are
described in a series of reviews.41 By contrast, dedicated collections of sponges to specifically
isolate and characterize metabolites from sponges in the Arctic and Alaskan regions have been
few and far between as illustrated in Figure I.10. Yet, the biodiversity of the Gulf of Alaska and
British Columbia in particular, is known to be considerable. The discovery of new species with
diverse bioactivity as indicated by the initial screen of the 2010 collection of Aleutian sponges
and previous collections made by our group in the general area bodes well for the future of new
and valuable bioactive compounds.

15

A. Discorhabdins (3-8); Aleutian
Islands collection
B.

Monanchocidins (9-13)

C.

Pyridinium alkaloids (14,15)

D. Diketopiperazines (16)
E.

Polymastiamides (17-22)

F.

Cyclic peroxides (23,24)

Figure I.10. A view of the earth directly over the North Pole which indicates the collection sites
that yielded the bioactive metabolites presented in this review. The following image was created
using Google Earth (version 6.1.0.5001).

ISOLATION EFFORTS FOR NEW SPECIES OF GUITARRA
Taxonomic Overview
A new undescribed species of Guitarra (Order Poecilosclerida, Family Guitarridae) was
amongst the six poecilosclerid sponges identified and was further investigated for bioactive
components. The specimen was dredged from a depth of 94 m from the Aleutian Islands, where
it was moderately common. In life the sponge forms a massive encrustation with deep cracks
outlining polygonal “plates”. The texture is tough, the color in life is peach to orange-yellow. A
photograph of the sponge outside of water can be seen in Figure I.11. The sponge is
characterized by long megascleres (oxeas 580–600 µm long) and three forms of microscleres
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(biplacochelae, c. 47 µm long, in addition to the usual placochelae, c. 47 µm long, and small,
spiny bipocillae and anisobipocillae, c. 15 µm long). The most closely comparable species to
Guitarra n. sp. is G. abbotti Lee, 1987, from the Cordell Bank, northern California. Guitarra
abbotti also has the unusual biplacochelae in addition to the usual oxeas, placochelae, and
bipocillae microscleres, but these differ considerably in length from those in Guitarra n. sp. The
oxeas of G. abbotti are half the length (330 µm) of those in Guitarra n. sp., and there are two
sizes of placochelae in the former species, the larger of which is twice the length of those in
Guitarra n. sp. (83 µm long) with the smaller size being 37 µm long. The biplacochelae of G.
abbotti are slightly smaller (36 µm) than those in Guitarra n. sp, and the bipocillae are half the
length (7 µm) of those in the new species.

Figure I.11. An out-of-water photograph of the new species of the genus Guitarra.
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Isolation Methods
The new species of Guitarra was examined because of initial activity from the disc
diffusion assay against B. cereus. The complete 1 kg (wet wt.) specimen was extracted with ethyl
acetate to yield 11 g of crude material. The resulting extract was subject to a silica flash column
and the active material eluted from a fraction of 1:1 hexane and ethyl acetate. The resulting
fraction (483 mg) was subject to separation using 3 cm diameter LH20 column and a 1:1 mixture
of dichloromethane and methanol. The activity was traced to a group of fractions that were
combined and subjected to further separation on a Waters Delta HPLC (λ 280 nm) using a 4.6 ×
150 mm Phenomenex Luna Silica column employing a linear gradient from 100% pentane to
100% dichloromethane over 75 min. The HPLC separation yielded sub-miligram amounts of two
pure compounds that were identified as 4-hydroxybenzaldehyde (25) and indole-3carboxaldehyde (26) (Figure I.12) based on comparison of standards with 1H-NMR and GC-MS
results. Spectral information can be seen in Figures I.13-I.16.

Figure I.12. 4-Hydroxybenzaldehyde (25) and indole-3-carboxaldehyde (26) isolated from a new
species of Guitarra.
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Figure I.13. 1H NMR spectrum of 25 in CDCl3.

121.2 m/z

Figure I.14. GC-MS analysis of 25.
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Figure I.15. 1H NMR spectrum of 26 in CDCl3.

144.2 m/z

Figure I.16. GC-MS analysis of 26.
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Discussion
The antibacterial activity of a crude extract against Bacillus cereus guided the isolation
and identification of two known aldehydes previously identified from the new sponge species of
the genus Guitarra. Indole-3-carboxaldehyde was isolated previously from marine Pseudomonas
species.42 Using purchased standards of these molecules, the original bioactivity of the crude
extract was not reproduced. In spite of this result, 4-hydroxybenzaldehyde has been reported as
active against some bacterial and yeast species including Staph. aureus, E. coli, and P. oryzae,
and also against some tumor cell lines.43, 44 Interestingly, it has also been isolated from a
perennial saprophytic herb Gastrodia elata and demonstrated unique bioactivity. Assays
performed in vivo using rats showed that 4-hydroxybenzaldehyde has anticonvulsive and
antiepileptic properties.45
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CHAPTER 2

MONANCHOCIDINS WITH BROAD SPECTRUM BIOACTIVITY FROM A NEW SPECIES
OF MONANCHORA

INTRODUCTION
The Aleutian Islands Archipelago is a chain of 14 major islands and roughly 55 smaller
islands that extend 1100 miles from Alaska westward towards Russia to the final island Attu
Island, AK. The Aleutian Islands, formed by years of volcanic activity, separate the Bering ea
to the orth from the acific cean.

ater temperatures around the leutian slands range from

8C at the surface to around C etween depths of 200 and 400 m.46 The cold and dark
environment provides an unexplored and rich diversity of undiscovered marine fauna. The initial
sponge collection in the Aleutian Islands provided 28 new species from a total of 102 collected,
and now an aggregate of 125 species have been characterized from the region.47 A preliminary
taxonomic break down of the species from the phylum Porifera of the Aleutian Islands comprises
10 calcareous, 20 hexactinelli, and 95 demosponge species, yet there is still estimated to be
hundreds of species from Porifera yet to be discovered from the Aleutian Islands region.47
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Among the 95 species of demosponge native to the Aleutian Islands are three members of
the genus Monanchora belonging to the family Crambeidae. M. alaskensis, M. pulchra, and M.
laminochela have all been characterized from the region.47
M. alaskensis (Figure. II.1) is uncommon to the Pacific Ocean but can be found in the
bedrock and cobble of parts of the Aleutian Islands and Bering sea where it is seen at depths
between roughly 150 and 350 meters and water temperatures between 1.4 and 6.

C.47

Figure II.1. M. alaskensis collected from the Aleutian Islands, AK.47

M. pulchra is found in great numbers in the Aleutian Islands, as well as the Canadian
Pacific coastline, and other archipelago in the region. Found in more shallow regions than M.
alaskensis, M. pulchra is typically located attached to bedrock and boulders between depths of
80 and 330 meters.47 M. pulchra is orange-colored in life but can be seen in varying shades.
Figure II.2 displays photographs of both M. pulchra in natural habitat as well as out of the water.
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Figure II.2. Photographs of M. pulchra: the same specimen out of water (A) and in life
(B); another photograph of M. pulchra in life (C)47

M. laminachela is reported as common in the Aleutian Islands but has not been reported
anywhere else worldwide. Found at greater depths than both M. alaskensis and M. pulchra, M.
laminachela grows attached to boulders and cobbles between roughly 200 and 500 meters.47
Photographs of M. laminchela both out of water and in life can be seen in Figure II.3.
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Figure II.3. Photographs of the same specimen of M. laminachela out of water (A), out of
water with other organisms (B), and in life (C)47

Members of Monanchora have been the source of bioactive secondary metabolites such
as the cytotoxic monanchocidins isolated for M. pulchra presented in Chapter 1, Figure I.3. Here
we present a new species of Monanchora collected in Aleutian Islands, AK, which produces
known and new analogues of bioactive secondary metabolites previously isolated from M.
pulchra.

Taxonomic Overview
The specimen has been compared to the three known species of Monanchora in the
Aleutian Islands area: M. alaskensis (Lambe, 1894), M. pulchra (Lambe, 1894) (2010-AK-48)
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and M. laminochela Lehnert et al. 2006. It is neither of these three, presenting much smaller
megascleres and microscleres overall. The specimen is a new and undescribed species of
Monanchora. A post-collection photograph is shown in Figure II.4.

Figure II.4. A post-collection photograph of a new Monanchora sp. collected in the Aleutian
Islands, AK (51.6415, -177.45301)

Bioactivity
The crude extract of the new Monanchora sp. was active in a variety of assays against
opportunistic infectious organisms, Plasmodium falciparum (malaria), hepatitis C virus, and the
disc diffusion assay mentioned in Chapter 1.
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Table II.1. IC50 values in µg/mL for the ethanol crude extract of the new species of Monanchora
collected in the Aleutian Islands, AK. (C. albicans, C. glabrata, C. krusei, A. fumigatus, C.
neoformans, Staph. aureus, Methicillin-resistant Staph., E. coli) *Amphotericin B and
ciprofloxacin as a control
C. albicans C. glabrata

C. krusei

A. fumigatus C. neoformans

Staph.
MRS E. coli
aureus

Crude extract

23.07

4.51

3.42

21.06

2.77

6.03

Amphotericin B

0.428

1.04

1.599

0.293

0.695

-

Ciprofloxacin

-

-

-

-

-

5.49 17.75
-

0.082 0.091 0.003

Isolation Methods
The specimen was lyophilized and the subsequent 60 g dry weight sample was extracted
with ethyl acetate followed by ethanol. The resulting ethanol extract (14.35 g wet) was subjected
to a liquid-liquid partition. The extract was partitioned between 200 mL of water and 200 mL of
ethyl acetate three times. The resulting precipitate formed from the partition was removed to
yield 174.3 mg of white powder, and the organic layer was separated and dried to yield 38.1 mg
of dark green oil. The resulting aqueous layer was subject to partition with n-butanol three times.
These layers were separated and the water fraction yielded 3.9 g of white powder while the
butanol fraction gave 1.5 g of a viscous orange liquid. The four fractions resulting from the
liquid-liquid partition were submitted for bioactivity with the results shown in Figure II.2.
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Table II.2. Monanchora sp. bioactivity results (IC50 values, µg/mL) against a number of
opportunistic infections for the fractions resulting from the ethanol extract undergoing liquidliquid partition.
C. albicans C. glabrata C. krusei A. fumigatus C. neoformans Staph. aureus MRS

E. coli

23.07

4.51

3.42

21.06

2.77

6.03

5.49

17.75

2.51

1.63

1.96

9.06

<0.8

1.52

1.40

7.08

EtOAc

-

-

-

-

-

-

-

-

Precip.

-

8.73

-

-

14.25

-

-

-

Water

-

-

-

-

-

-

-

-

Crude
n-butanol

With all bioactivity retained in the n-butanol fraction, this material was subjected to
separation using a 6 cm Sephadex LH20 with a 1:1 mixture of dichloromethane and methanol. A
flow rate of 2 mL/min was employed with fractions collected every 30 minutes to give 12
fractions. All fractions were screened for bioactivity using the disc diffusion assay against B.
cereus. Fractions 6-9 proved to possess bioactivity (Figure II.5).

Figure II.5. Zones of inhibition of crude fractions 6-8 from the Sephadex LH20 separation in
comparison to the kanamycin control in the middle of the plate. Fraction 9 also retained
bioactivity but was tested on a different plate.
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Fractions 6 (229 mg), 7 (430 mg), 8 (111 mg), and 9 (20 mg) were combined to conserve
material before purification. The mixture was subjected to a reversed phase C18 cartridge
(Phenomenex Strata C18-E, 55µm, 70A) to give four fractions as follows: 100% water (22 mg),
1:1 water:methanol (104 mg), 100% methanol (245 mg), and 100% chloroform (42 mg). These
fractions were tested for bioactivity using the disc diffusion assay against B. cereus. The results
are shown in Figure II.6.

Figure II.6. Zone of inhibition for fractions 2 (1:1 water:methanol) and 3 (100% methanol) in
relation to the kanamycin (K).

Using reversed phase C8 HPLC, Phenomenex (5 micron, 250 x 21.2 mm) employing a
gradient of 1:9 (acetonitrile:water) to 100% acetonitrile over 60 minutes (monitored at λ 245
nm,10 mL/min), 40 mg of active fraction 3 from reversed phase VLC yielded a purified sample
of monanchocidin A (Figure II.12) was obtained by splitting the UV signal into multiple
fractions.
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RESULTS AND DISCUSSION
Fractions 2 and 3 contained mixtures of closely related metabolites that are not easily
separated. The 1H-NMR (Figure II.7), 13C-NMR, and mass profiles of these fractions reveal that
they contain a group of molecules known as monanchocidins (Figure II.8) that have been
recently published.20, 21 The group of compounds is highlighted in Chapter 1 as compounds
isolated from sponges in the Arctic region.

Figure II.7. 1H-NMR spectrum in CD3OD of fraction 3 which contains monanchocidin A and
derivatives from a new Monanchora sp.
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Figure II.8. Structures of monanchocidins isolated from M. pulchra.20, 21

The structural difference between the known monanchocidins is minimal, which provides
difficulties in the purification of mixtures. The two distinct differences reside in the guanidine
region of the molecule in which two of the described compounds contain a 7-membered oxygen
heterocyclic ring (moiety A) and three of the compounds contain a 5-membered oxygen
heterocycle (moiety B). The two distinct reported moieties are displayed in Figure II.9. This
particular difference is not so easily distinguishable in that the molecular weight of the
compounds remains identical. The other difference among the known monanchocidins is the
length of the alkyl chain that connects the guanidine portion to the other heterocyclic region,
which is ubiquitous among all analogues. These slight differences provided barriers for
purification and characterization of potentially new compounds.

Figure II.9. The two distinct guanidine moieties of reported monanchocidins.
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Because of the difficulties of separating these compounds, the components of the mixture
were classified through LCTOF-MS. Using a Bruker Daltonics LCTOF-MS system,
monanchocidins with different alkyl chain lengths were identified by using mass (m/z) extraction
of predicted molecular weights from the total ion chromatogram for both bioactive fractions 2
and 3. The results and predicted compounds are displayed in Figures II.10 and II.11 with
unreported molecular weights indicated with a star.

Figure II.10. Extracted ion traces of various monanchocidins in bioactive fraction 2 (Total Ion
Chromatogram on top). Mass values present at significant intensities that have not been reported
are indicated by a star.
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Figure II.11. Extracted ion traces of various monanchocidins in bioactive fraction 3 (Total Ion
Chromatogram on top). Mass values present at significant intensities that have not been reported
are indicated by a star.

Monanchocidin A, the analogue in series, has a molecular weight of 859 Da. All
predictions were based off of varying numbers of methylene units composing the alkyl linker
chain in the molecule. As indicated by the TIC in Figures II.10 and II.11, the potentially new
monanchocidins cannot be easily purified from the mixture. Some of the extracted ion
chromatograms reveal two distinct mass signals with probable indication of the two distinct
guanidine moiety portions of the molecule seen in Figure II.9.
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The utility of the bioactivity of these compounds will be further investigated using the
acquired pure sample of monanchocidin A. The 1H-NMR, 13C-NMR, MS, and comparison with
published 13C-NMR data can be seen in Figures II.12, II.13, II.14, and Table II.3.

Figure II.12. 1H-NMR spectrum of monanchocidin A dissolved in CD3OD.
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Figure II.13. 13C-NMR spectrum of monanchocidin A in CD3OD.

+

[M + 2H]

Figure II.14. Mass spectrum analysis of monanchocidin A.
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+

[M + H]

Table II.3. 13C-NMR chemical shift comparison between experimental data and reported20
monanchocidin A in CD3OD. Carbons indicated with (-) were reported as overlapped.
Experimental (ppm)
Published (ppm)
Experimental (ppm)
Published (ppm)
172.61
169.81
150.00
135.98
129.89
95.94
89.66
82.22
82.01
81.33
78.29
72.66
68.24
54.85
54.21
50.75
42.59
38.89
37.99
37.67
36.02
35.57

34.01
33.25
32.94
32.85
32.33
31.27
30.68
30.64
30.57
30.55
30.48
30.33
27.56
27.51
26.50
26.24
26.20
26.06
21.96
19.34
13.75
10.01

173.6
170.8
151.1
136.9
130.7
96.7
90.6
83.3
83.2
82.4
79.2
73.5
69.2
55.4
55.3
51.5
43.3
39.9
38.6
38.4
36.7
36.5
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34.8
34.0
33.5
33.2
33.2
28.3
28.2
27.4
27.0
26.8
22.5
20.0
14.3
10.6

CHAPTER 3

MICROBIOME AND METABOLOME STUDIES OF THE SPONGE
ACANTHOSTRONGYLOPHORA SP. AND THE POTENTIAL ROLE OF THE SPONGEASSOCIATED BACTERIA MICROMONOSPORA SP. M42 IN THE HOST METABOLOME
The interaction between the microbiome and the host organism plays a crucial role in the
development of host-microbe ecosystems. Nearly all organisms exist in coordination with a
number of bacterial and fungal species that compromise their particular microbiome. These floral
communities typically live amongst their host in one of three types of symbiotic relationship
including commensalism, mutualism, and parasitism. Symbiotic microorganisms have been
shown to play a number of beneficial roles for the host organism including aid in primary
metabolism through nitrogen fixation and transformations in marine invertebrates,48 growth
promotion in plants ,49 and provision of critical chemical defense systems for marine
invertebrates,50 plants,51 and humans 52 among other organisms. The specific roles of microbes in
the host life cycle can be greatly dictated and more precisely defined by understanding its small
molecule secondary metabolism.53 Thousands of secondary metabolites have been
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discovered from microorganisms with an array of different bioactivities that can significantly
alter the dynamics of open biosystems upon production.
The investigation of microbial symbiosis with larger host organisms provides an
interesting frontier for natural product discovery. Understanding the intended purpose of
microbial secondary metabolism to host specific responses can help evaluate the potential
therapeutic use or other real world application of newly discovered metabolites. Specific
examples of host-microbe interactions have been reported in a variety of different species types
including insects, plants, humans and other mammals, other microorganisms, and most relevant
to this work, marine invertebrates. Actinobacteria are hypothesized to provide antibiotic defense
against pathogenic microbes in wasp species with more than 200 strains isolated and many
producing a myriad of bioactive secondary metabolites.54 In a more complex biosystem ant
species that depend on the growth of certain fungi for nutrition possess an associated
actinobacteria of the genus Pseudonocardia that retains antibiotic activity towards parasites that
attack the ant food source.55 In plants, microbial symbionts have shown to have a number of
positive and negative effects on host organisms.56, 57 Associated microbes can produce antibiotic
metabolites that aid in host defense mechanisms58 or can also induce host susceptibility to other
infections of herbivores.59 Alternatively, Pseudomonas species have been demonstrated to
produce small diketopiperazines that influence root growth and architecture of its host plant.49
An increased complexity of plant-microbe interactions has been presented with the report of
plant-pathogenic fungi, Rhizopus sp., that rely on harbored symbiotic bacterial species for toxin
production.60 In addition, the enormous biosynthetic capabilities of some plant-associated
bacteria has been illustrated through recent research, including the discovery of 65 total
biosynthetic gene clusters in three different strains of Frankia sp. derived from actinorhizal
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plants.61 The proficiency of microbial secondary metabolism in association with plants suggests
a number of symbiotic roles, many of which remain to be described. The normal flora associated
with the human body has yielded important benefits for the human host. These include
providing physical and chemical defenses on the epidermal layer as well as within the
gastrointestinal lining and contributing enzymes for digestion and metabolism all represent
valuable benefits from human associated microorganisms.62 The abundance and diversity of the
human microbiome indicates an articulate relationship between microorganisms and humans. As
of 2011, the Human Microbiome Project established by the NIH has deposited over 600
referenced genomes with up to 60 million predicted gene products from normal human flora63
with anticipation of understanding human-microbe interactions for therapeutic value.
Host-microbe interactions in marine invertebrates share common characteristics with
terrestrial models in that growing evidence reveals microorganisms are responsible for chemical
defenses through secondary metabolite production. However, the diversity and physiology of the
microbiome are more difficult to understand because of its unique environment and struggle to
successfully culture these microbes in the laboratory.64 65 Microbial species have been identified
and studied for their symbiotic relationships in many marine microorganisms, namely tunicates
and sponges. Special symbiosis between the cyanobacteria Prochloron didemni and the tunicate
Lissoclinum patella has been studied for its extremely large yield of bioactive patellamide
compounds.66 Although the patellamides could not be detected when the bacterium was
separated from the host, the biosynthetic gene clusters were definitively identified in P. didemni,
suggesting the host-microbe interactions play a crucial role in patellamide biosynthesis. In
addition to the varying production of promising bioactive metabolites isolated from L. patella,
other studies of this symbiosis explain the importance of P. didemni in aiding the tunicate in both
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primary and secondary metabolism to ensure its survival,67 providing further motivation for
researching host-microbe symbiosis for the benefit of drug discovery. Furthermore, tunicatederived α-proteobacteria have been characterized as a producer of didemnin B, which was the
first marine drug to be tested in humans.68 Similarly in sponge species, early studies regarding
their microbial communities showed the microbiome to be somewhat uniform and
phylogenetically distinct from microbes characterized from other marine sources.69 Other studies
of the sponge microbial community provided evidence towards the vertical transmission of the
microbiome in the sponge Corticium sp.,70 suggesting the importance of the microbial
community in proper sponge development. Early work in sponge host-microbe research
suggested that two different types of metabolites were produced by two distinct microbial
inhabitants of the sponge Theonella swinhoei by analyzing distinct cell types using transmission
electron microscopy.71 This data provided both evidence for a possible microbial origin and cell
specific sequestration of secondary metabolites as well as the complexity of the sponge
microbiome.
In this research effort, we present a thoroughly interrogated microbiome and metabolome
of the sponge Acanthostrongylophora sp. (Fig. III.1). From the complex microbiome, a small
subset of 12 bacteria could be successfully cultured in the laboratory thus far. One bacterium in
particular, identified as Micromonospora sp. M42 (Fig. III.1), appears to play a critical role in
defensive secondary metabolism and potentially growth of the sponge. Using 16s rRNA gene
sequence analysis, the sponge-associated microbial community was assessed and microbial
isolates were obtained. This study revealed that Micromonospora sp. M42 to be capable of
biosynthesis of manzamine A, a metabolite found in high yield in all Acanthostrongylophora sp.
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as well as the producer of a series of diketopiperazines which possess a variety of bioactivities
and may play a role in sponge growth and integrity.

Figure III.1. Acanthostrongylophora sp., a common Indo-Pacific manzamine producing sponge
with the image of a colony of Micromonospora sp. strain M42 with orange mycelial growth and
black spores. Manzamine A, B, and 8-hydroxymanzamine A.

Results
Microbiome Analysis of the Sponge Acanthostrongylophora sp.
The 16S rRNA gene sequence analysis of the sponge-associated bacterial community on
a library of 117 clones showed three dominating groups, deltaproteobacteria (30%, n=36),
chloroflexi (19%, n=23), and actinobacteria (16%, n=19), the remainder of the community
includes acidobacteria, gammaproteobacteria, alphaproteobacteria, spirochaetes, and CFB related
bacteria (Fig. III.2). The Acanthostrongylophora sp. bacterial community is similar to previously
reported sponge-associated bacterial communities in being highly diverse with many of the
clones having sponge-associated bacteria as their closest relative. Interestingly, a cluster of 23
deltaproteobacteria sequences were identified, which are closely related to the potentially new
genus Plakortis sp. sponge clone PK003.69 Actinobacteria are one of the major components of
the bacterial community in Acanthostrongylophora sp., as seen in previously reported sponge
community analysis.65, 72
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Figure III.2. Neighbor-joining phylogenetic tree based on 16S rRNA gene sequence analysis
showing the bacterial diversity of Acanthostrongylophora sp.
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Denaturing gradient gel electrophoresis (DGGE) comparison of the sponge bacterial
community to the surrounding water column (Fig. III.3) showed that the sponge bacterial
community was both distinct and more diverse than the water column. Numerous high GC
bacteria (possibly actinobacteria) were undetectable in the water column, but clearly visible in
the sponge. Visualization of actinobacteria within Acanthostrongylophora sp. tissue by
fluorescence in-situ hybridization (FISH) using a high-GC probe specific for actinobacteria 73
revealed distribution throughout the sponge. Clusters of 20 to 50 high-GC bacteria were
randomly distributed throughout the mesohyl (Fig. III.4).

C WS

Figure III.3. DGGE analysis of a PCR negative control (C), seawater (W), and
Acanthostrongylophora sp. (S). The increase in bands in the sponge sample indicates a higher
diversity in the sponge than in the surrounding water column.
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Figure III.4. Epifluorescence micrograph section of Acanthostrongylophora sp. mesohyl tissue
visualized by FISH. The mesohyl region was hybridized with Cy-3 labeled HGC69a probe.

Isolation of sponge-associated heterotrophic bacteria was performed. Standard marine
agar 2216, actinomycete media ISP2, and starch casein agar were modified by the addition of
NaCl for sponge derived actinomycete isolation and yielded 11 pure cultures, one
gammaproteobacteria (M37), two alphaproteobacteria (M31, M36), five firmicutes (M28, M29,
M39, M34, M40) and three actinomycetes (M41, M42, M62). The two alphaproteobacteria
isolated belong to a group of common sponge symbionts that are vertically transmitted via
sponge larvae.74
Multi-spectrum bioactive manzamine alkaloids have been isolated in large quantity and
variety from Acanthostrongylophora sp.75 and a myriad of other species,76 suggesting the
potential importance of a sponge-associated microbe in symbiosis through manzamine
metabolite production. Thus, each Acanthostrongylophora sp. isolate was tested for the presence
of manzamines by TLC with Acanthostrongylophora sp. isolated MA and 8OHMA standards
and detected by the alkaloid specific Dragendorff solution (Fig. III.5, left inset). LC-TOF-MS
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analysis of isolates testing positive by TLC quickly identified a single bacterial strain (M42)
producing a compound with identical retention time, mass and 1H-NMR of sponge derived MA,
thus confirming the identity of the metabolite (Fig. III.5). This strain was identified as a
Micromonospora sp., closely related to Micromonospora chalcea (X92594) through
phylogenetic analysis, and thus named Micromonospora sp. M42 (Fig. III.6).
Bacterial derived

ISP2 YM
+M42

ISP2 YM
Media

Sponge standard

Standards

Figure III.5. Chemical confirmation of MA production. Left insert) TLC of alkaloids produced
by M42 in either ISP2 or YM, A and B, respectively, compared to media and standards. Right
insert) 1H-NMR analysis comparison of sponge derived MA. Main image) 1H-NMR of bacterial
derived MA.
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Figure III.6. Phylogenetic analysis based on 16S rRNA gene sequence of cultured bacteria
isolated from sponge Acanthostrongylophora sp. noted in bold.

Genome Sequencing and Metabolomic Analysis of Micromonospora sp. M42
A great portion of the genome of Micromonospora sp. M42 has been sequenced by
Clardy and coworkers and deposited to the Broad Institute Streptomyces database.77 The
annotation of the M42 genome was retrieved for analysis from this database. The sequencing
revealed 14 super contiguous (supercontigs) segments of DNA with an estimation of 6.78 Mbp
in total. Of the 6.78 Mbp, nearly 6.7 Mbp are found on one supercontig. The entire annotation
contains multiple small gaps of unidentified sequence.
The entire available genome annotation of Micromonopsora sp. M42 was screened using
Antibiotics and Secondary Metabolite Analysis Shell (antiSMASH).78 The antiSMASH program
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screened the inputted sequence against a database containing identified secondary metabolite and
antibiotic gene clusters including polyketide synthases (PKS), non-ribosomal peptide synthases
(NRPS), terpene biosynthetic enzymes, hybrid clusters, and others. The screening revealed at
least 17 biosynthetic gene clusters in M42. Although we were unable to specifically designate
the products of these clusters because of gaps in the sequence and a small degree of relation
between manzamine A to known biosynthetic genes, enough sequence was available to identify
biosynthetic clusters by family. Among the 17 identified secondary metabolite gene clusters a
total of four PKS, one NRPS, six hybrids, five terpenes, and one lantibiotic were discovered. The
gene cluster descriptions are presented in Table III.1. The analysis of the genome of M42 reveals
a great number of genes that code for machinery necessary to produce an array of secondary
metabolites that have yet to be described from the species that potentially play roles in sponge
symbiosis. A circular mapping of the genome of M42 containing the discovered secondary
metabolite biosynthetic gene clusters was also performed (Fig. III.7).
Table III.1. Assignment and associated genomic data for each of the 17 secondary metabolite
gene clusters of Micromonospora sp. M42.
Cluster Assignment
pks1
hyb1
hyb2
hyb3
pks2
terp1
hyb4
hyb5
pks3
nrps1
lan1
terp2
terp3
pks4
terp4
terp5
hyb6 (mnz )

Predicted Product
Type
%G+C Size, kb
Unknown polyketide
Type I PKS 74.9
62
Unknown
PKS-NRPS 73.5
89
Unknown
PKS-NRPS 74.2
62
Unknown
PKS-NRPS 73.7
77
Unknown polyketide
Type II PKS
74
34
Unknown terpene
Terpene
73.3
22
Unknown
PKS-NRPS 75.2
65
Unknown
PKS-NRPS 73.6
64
Calicheamicin-like gene Type I PKS 73.2
48
Unknown peptide
NRPS
70.2
56
Unknown
Lantibiotic
69.4
26
Unknown terpene
Terpene
73.4
22
Unknown terpene
Terpene
73.4
21
Unknown polyketide
Type III PKS 72.9
32
Unknown terpene
Terpene
74.4
23
Unknown terpene
Terpene
74.1
23
potential manzamine
PKS-NRPS 74.7
115
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Cluster Location
Promoter
136 - 61803
LuxRx2
174331 - 263486
LuxRx3 TetR
355561 - 417554
GntR, ArsR, LuxR
438999 - 515341 LuxR, LacI, SARP
665765 - 699240
SARP LuxR
890218 - 912274
LuxR
1361677 - 1426648
unknown
1520107 - 1584818
SARP
2226963 - 2274369
AraC HalR
2268788 - 2324751
MarR
2487725 - 2513477
LuxR
4018209 - 4040214
MarR AsnC
4120455 - 4141767
LysR
4722907 - 4754839
SARP
6231949 - 6254523
TetR MarR
6398495 - 6421847
TetR
6587812 - 6702591
LacI

Figure III.7. A circular mapping of the available genome of Micromonospora sp. M42. The
outside ring presents the biosynthetic gene clusters in their position along the genome. The
middle ring illustrates normalized GC content while the inner ring shows a normalized plot of
GC skew.

Metabolites Identified from Micromonospora sp. M42 and Potential Role in
Acanthostrongylophora sp. Symbiosis
Fermentation studies of M42 were performed to confirm the production of manzamine
and also assess other secondary metabolites to further understand the role of M42 in
Acanthostrongylophora sp. symbiosis. Manzamine alkaloids were purified (Fig. III.5) from the
media by extraction into chloroform and the extracted material subjected to two HPLC
purification steps, first reverse phase C8 followed by normal phase silica both monitored at 350
nm. Analysis of manzamine A (MA) production over 16 days was performed in triplicate and
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revealed that MA is initially produced in a linear fashion and then metabolized by the organisms
resulting in undetectable levels of MA (Fig. III.8A-C). The peak of production occurred after 4-7
days of incubation, apparently corresponding to log phase growth (Fig. III.8D), and by day 10 no
MA was detected, after the log phase has ended. This is intriguing as the molecule is
extraordinarily stable in all solvents as well as during in vitro and in vivo evaluations. Further
stability studies revealed that degradation of the metabolite is not caused by solvent; however,
we cannot rule out external enzymatic degradation or sequestration into cellular components.
While these experiments show that M42 is capable of producing MA, they also introduce
complications of further metabolism of the molecule. Further support of the biogenesis of MA by
M42 was obtained through biosynthetic studies. In the first biosynthetic scheme for MA
proposed by Baldwin and Whitehead,79, 80 a pyridinium dimer undergoes a Diels-Alder reaction
followed by hydrolysis to generate an aldehyde similar to ircinal A. This aldehyde can further
react with tryptamine through a Pictet-Spengler reaction, producing manzamine D in a similar
biochemical mechanism as plant strictosidine synthase.81 Further oxidation would yield the
aromatic β-carboline ring system. Based on this proposed biosynthetic route tryptamine and
ircinal A were added to M42 cultures in ISP2 media and resulted in an approximate 5-fold
increase in MA production demonstrating the ability of M42 to convert precursors to MA.
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Figure III.8. Production curve of MA from M42 in ISP2. A-C are production charts normalized
to mg MA/ g cell mass. Production increases in the first 7 days and dramatically drops
afterwards. D is a growth curve of the bacteria based on OD 600 measurements. This data
suggests that MA is best produced during logarithmic growth.

Interestingly, additional fermentations yielded a series of seven additional small-molecule
compounds that display a broad range of bioactivities including tryptophol (1), Nacetyltryptamine (2), phenethylacetamide (3), brevianamide F (cyclo-(L-Pro-L-Trp) (4), cyclo(L-Pro-L-Phe) (5), cyclo-(L-Pro-L-Leu) (6), and cyclo-(L-Pro-L-Val) (7) (Fig. III.9). Structural
information can be seen in supplementary Figures III.13-III.30. These compounds were purified
from extraction using methanol-chloroform, followed by a reversed phase C18 flash column and
subsequent C18 then NH2 HPLC. In the fermentations that yielded compounds 1-7, no
manzamine related molecules were detected. It is possible that the biosynthetic machinery
necessary for manzamine production is plasmid derived and can be easily lost or acquired
through horizontal gene transfer. The wide distribution of manzamine alkaloids in different
sponge species suggest that the machinery is able to be acquired by multiple microorganisms,
most suitably in plasmid form. Other research suggests that secondary metabolite production can
decrease and even become non-existent after multiple generations of subcultures.82 The
production of camptothecin by the endophytic fungi Fusarium solani in axenic culture initially

50

decreased and then was eliminated after multiple subcultures.83 It was also reported that
reinoculation into host plant species did not restore metabolite production, indicating that
biosynthetic machinery can be quickly mutated in axenic culture. These data reveal the
difficulties of producing large scale drug candidates in laboratory settings from host-associated
microbes, but offers insight towards the reliance on host and other microbe mutualism in the
quality production of some compounds, as appears to be the case for Micromonospora sp. M42.

Figure III.9. Tryptophol (1), N-acetyltryptamine (2), phenethylacetamide (3), and four
diketopiperazines composed of cyclo(L-Trp, L-Pro) (brevianamide F) (4), cyclo(L-Phe, L-Pro)
(5), and cyclo(L-Pro, L-Leu) (6), cyclo(L-Pro, L-Val) (7) isolated from Micromonospora sp.
M42.

The significance of the production of the manzamine alkaloids and compounds 1-7 by
M42 for the development and protection of the host Acanthostrongylophora sp. can be predicted
from examination of what is known of the properties of the metabolites. Manzamine A was
originally described as a possible cancer lead, but since then has shown significant activity
against Plasmodium falciparum including single dose clearance and a 2-7 fold greater activity
compared to artemisinin in vitro.84, 85 Mycobacterium tuberculosis,86 and serine/threonine
kinases, such as GKS3-β and CDK ,87 are also inhibited by MA. Treatment with MA impedes
metastasis in cancer cell lines and sensitizes them to TRAIL-induced apoptosis.88 The broad
spectrum antibiotic activity of MA appears to provide an extensive chemical defense system for
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the host sponge. We have shown that MA has an inhibitory effect on the growth of M42 at
concentrations exceeding 12µg/mL (Figure III.10) which is much lower than the concentration
found in the sponge supporting the sequestration of the metabolite by the host. These data
indicate that M42 could provide chemical defense for Acanthostrongylophora sp. in exchange
for habitat and the ability to sequester large amounts of manzamine alkaloids in a manner that is
not lethal to the bacteria. As for compounds 1-7, all products have been reported from an
assortment of marine and terrestrial organisms and display a number of bioactivities including
antimicrobial, antitumor, and cytoprotective properties.89, 90 These small molecules could also
benefit the sponge with chemical defenses. In addition to antibiotic activity, compounds 5-7 are
reported as antifouling agents that inhibit the attachment of barnacle larva.91 These compounds
may help maintain the integrity and proper development of Acanthostrongylophora sp.
environment by not allowing other organisms to inhabit areas directly on or around the sponge.
Some of these metabolites may aid in the development and growth of sponge species. Three
diketopiperazines, cyclo(L-Pro-L-Val), cyclo(L-Pro-L-Phe), and cyclo(L-Pro-L-Tyr), were
shown to be produced from plant-associated Pseudomonas aeruginosa and promote growth and
alter root architecture in plants by mimicking the hormone auxin.49 Two of the three active
components (4, 7) were isolated from M42 and may play a role in sponge growth, although a
lengthy study is necessary to identify any correlation. Furthermore, the four diketopiperazines 47 were identified in Acanthostrongylophora sp. crude extract using standards and LC-MS
(Figure III.11). Compounds 1-3 were not detected in the sponge extract, and 4-7 appeared to be
in low amounts compared to the laboratory fermentation production which could likely be due to
their rapid metabolism in the marine biosystem by the host or other associated microbes.
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Figure III.10. Inhibition of M42 growth by MA. Increasing MA concentration inhibits the growth
of M42 in a dose dependent fashion.
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A

C

B

Sponge crude extract

Sponge crude extract

Standard

Standard

Co-injection

Co-injection

D

Sponge crude extract

Sponge crude extract

Standard

Standard

Co-injection

Co-injection

Figure III.11. LC-MS traces of crude sponge extracts, standard compounds, and the co-injection
of both showing the extracted ion (m/z) for the compound of interest in each chromatogram. A)
cyclo(L-Pro, L-Leu) (6); B) cyclo(L-Pro, L-Val) (7); C) cyclo(L-Phe, L-Pro) (5); D) cyclo(LTrp, L-Pro) (Brevianamide F) (4). Standard LC-MS profiles correspond for 2µg on the column.
Elution was performed on reversed phase HPLC using a gradient of 15:85 MeOH:H2O to 100%
MeOH over 40 minutes.
Proposed biosynthetic origin and route for manzamine alkaloids
Using the antiSMASH software as well as NCBI genomic databases,92 a number of
potentially important biosynthetic enzymes in manzamine biogenesis were identified. The hyb6
cluster, identified through antiSMASH, contains the majority of the enzymes predicted in the
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biosynthesis of manzamine (mnz cluster). The biosynthesis initiates with formation of a
pyrollidinium monomer formed by the condensation of acetate units to nicotinic acid. A constant
supply of nicotinic acid can be maintained by the expression of MnzA, an amino hydroxyl
benzoic acid (AHBA) homologue. MnzA is predicted to convert a nicotinic acid degradation
product to nicotinic acid in a similar dehydration mechanism seen in the formation of AHBA
synthesis.93 The nicotinic acid unit is proposed to be activated by the adenylation domain found
in MnzB. This can subsequently be elongated using the PKS machinery in MnzE and MnzF. The
dimerization would proceed through an uncharacterized mechanism by an unknown enzyme. The
enzyme catalyzed Diels-Alder reaction is also catalyzed by an unidentified enzyme with no clear
relation to an identified natural Diels-Alderase.94 Following the Diels-Alder reaction the ring
opens to produce the carbon skeleton of ircinal A. MnzG is a putative Pictet-Spengler catalyzing
protein that can add tryptamine to the aliphatic chain previously produced. Currently, it is
unclear if this is clustered with hyb6; however, it is possible as hyb6 is located at the end of a
7Mbp contig separate of the MnzG containing contig. These two contigs could be adjacent to
each other, forming a complete Mnz cluster. The P450 homolog MnzD would form an epoxide
from the product of MnzG, producing manzamine B. Opening of the epoxide through proton
rearrangement, which may or may not be enzyme catalyzed, leads to manzamine A formation. A
reductive domain can remove or close the bottom ring of the structure. A putative biosynthetic
mechanism as well as a rough annotation of hyb6 is presented in Figure III.12. It is important to
note that the last 30kb of hyb6 is unpredictable because 30% (~10kb) of the sequence is
undefined.
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Figure III.12. Proposed biosynthetic scheme for manzamine alkaloids with genomic
representation of proposed machinery located in and adjacent to the hyb6 gene cluster.

Micromonospora sp. M42 Metabolome with respect to the entire Acanthostrongylophora sp.
Metabolome
With greater evidence for the biosynthetic capabilities of M42, its fingerprint and role
within the entire sponge microbiome and resultant metabolome became a focus. There have been
56

over 35 manzamine derivatives isolated from Acanthostrongylophora sp. to date. The genesis for
this diverse array of metabolites is likely the ability of the entire microbiome to carry out
biotransformation of the prototype manzamine core structure. The conversion of manzamine
alkaloids to a series of derivatives provides the symbiotic environment with varying chemical
properties that can be suitable for adaptation to current stressors. As a proof of principle
experiment, a series of biotransformation experiments have been conducted.95-97 MA was
incubated with terrestrial microbes and one isolated from the same sponge as M42, Bacillus sp.
VAN35 (M28). Under laboratory conditions, M28 converted MA into ircinal A. Terrestrial
bacteria and fungi were used as models for other biotransformation pathways for MA including
various Fusarium sp., Streptomyces sp., and Nocaridia sp. It was found that through incubation
of both marine and terrestrial microbes, MA could be transformed to related molecules originally
reported from the sponge, thereby providing another route through which the suite of metabolites
found in the sponge may be generated. An illustration providing routes to the manzamine-related
molecules from Acanthostrongylophora sp. from proven microbial biotransformations,
tryptamine-ircinal precursor feeding experiments, as well as plausible routes can be seen in
Figure III.13. The results of biotranformation studies show that microbial species are capable of
performing a series of oxidations, dehydrations, rearrangements, and other modifications to
manzamines that can logically explain the presence of most manzamine derivatives isolated from
the sponge. These studies offer further clarity on the effects of symbiosis between M42 and the
entire sponge microbiome on a chemical level.
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Figure III.13. Potential routes for Acanthostrongylophora sp. derived metabolites.
Biotransformation results using manzamine standards are displayed as well as plausible
explanation for related metabolites. Microorganisms: (1). Fusarium solani F0007, (2).
Micromonospora M42, (3). Fusarium oxysporium f.sp. gladioli ATCC 1113713, (4) Bacillus sp.
VAN35 (M28) (5). Streptomyces seokies, (6). Fusarium oxysporium ATCC 760114 (7).
Nocardia sp ATCC 2114514 were capable of transforming MA into a related metabolite. [(Ref.)
= 98, Plausible biosynthetic route for manadomanzamines in this reference]
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Conclusion
The complexity of host-microbe relationships drives the growth and development of
ecological systems of all environments, including the oceans. Here, the rich diversity of the
microbiome present in Acanthostrongylophora sp. in conjuncture with the myriad of bioactive
secondary metabolites isolated from the sponge, delivers evidence of the significance and
complexity of the symbiosis in the overall metabolome. Additionally, the biosynthetic
capabilities assessed in the sponge-associated Micromonospora sp. M42 genome displays the
ability of the bacteria to produce a number of compounds that would influence the success of the
host. Chemically, the secondary metabolites isolated have displayed a variety of activities that
can logically benefit the host, while the sponge provides a unique habitat for microorganisms
that have been proven exceedingly difficult to reproduce in laboratory environments. The
enzymatic capabilities of other microbes to biotranform manzamine alkaloids to other related
molecules that have been isolated from Acanthostrongylophora sp. illustrate the potential activity
of the entire sponge microbiome in the generation of the complex sponge metabolome.
Understanding the remarkable potential of the sponge microbiome and the influence it has on
secondary metabolism provides interesting insight into how this host-microbial relationship
ultimately impacts the diversity and final products that compose the complex metabolome of the
sponge.
Materials and Methods
Sponge Sampling. Specimens of Acanthostrongylophora sp. were collected by SCUBA diving
in Manado Bay, Indonesia at depths between 6 and 33 m. Sponges were transferred directly to
plastic bags containing seawater. Sponge tissue was stored frozen at -80˚C until used. The
sponge tissue was lyophilized prior to analysis.
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Total DNA Extraction from the Sponge Acanthostrongylophora sp. DNA was extracted from
lyophilized sponge tissue using a bead-beater method adapted from Pitcher et al. 99 Dried tissue
(4 g) was ground with a mortar and pestle and resuspended in 16 mL of TE buffer and 4 mL of
isoamyl alcohol.

The solution was transferred to a 50 ml bead-beater chamber (Biospec

Products, Inc.). Zirconia/Silica beads (0.1 mm and 1 mm) were added to 1/4 volume of the
chamber and homogenized four times in 1 min via the bead- beater. The solution was transferred
to a 50 ml tube, 10 ml of guanidium thiocyanate buffer was added, mixed gently, and transferred
to ice.

Ammonium acetate (10 M) was added to a 2.5 M final concentration.

Standard

phenol/chloroform extraction and chloroform/isoamyl alcohol extraction followed. DNA was
precipitated with cold isopropanol, cleaned with 70% (v/v) ethanol, and resuspended in TE
buffer (pH 8). DNA was quantified using a UV/Vis spectrophotometer.
Indonesian Sponge Acanthostrongylophora sp. Bacterial Clone Library. Polymerase Chain
Reaction (PCR) was performed using 100 ng of DNA with universal 16S rRNA gene primers 827f 100 and 1492r 101 using Hi-Fi Platinum Taq (Invitrogen). Cycling conditions were as follow:
initial denaturation at 94ºC for 5 min, 20 cycles of 94ºC for 30 sec, 48ºC for 2 min, 72ºC for 1.5
min, and a final extension of 5 min at 72ºC in a PTC-200 MJ-research thermal cycler (Bio-Rad).
PCR products were purified by electrophoresis in a 1% (wt/vol) agarose gel and bands of
approximately 1500 bp were excised and recovered using a gel extraction kit (Qiagen, Inc.).
Purified PCR products were cloned with a TOPO-XL cloning kit (Invitrogen) according to the
manufacturer’s instructions. The sequence of 108 clones (>500 bp) were manually aligned with
Phydit software.102 The tree was generated by the neighbor-joining algorithm103 implemented in
Phydit.

The robustness of inferred tree topologies was evaluated after 1,000 bootstrap

resamplings of the neighbor-joining data, and only values >50 % were shown.
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Isolation and Identification of Sponge-Associated Bacteria. Sponge extract was obtained by
grinding 1 cm3 of sponge tissue in sterile artificial seawater using a mortar and pestle. The
extract was plated in a serial dilution (100 to 10-4) on three different media types and incubated at
30°C for up to 3 weeks. Marine Agar 2216 (Difco), a non-selective medium, ISP2 (Difco) and
starch casein agar, both improve the growth of Actinobacteria and were supplemented with a
final concentration of nalidixic acid (10 μg/ml), cycloheximide (10 μg/ml), nystatin (2 μg/ml)
and 2% (wt/vol) NaCl. One morphotype of each bacterial colony was selected and subcultured
until pure. Isolates were identified by 16S rRNA gene sequence analysis. Bacterial isolates were
grown at 0˚C, in 0 ml roth of the medium from which they were originally isolated.

fter

days of growth, DNA was extracted from cell pellets using the Ultra-Clean Microbial DNA
Isolation kit (Mo Bio Laboratories Inc.). The 16S rRNA gene fragments were amplified by PCR
using Platinum Taq DNA polymerase High Fidelity, primers 8-27f ,100 1492 r 101 and sequenced.
Phylogenetic analysis of isolates sequence was carried as described above.
Culture Methods for Micromonospora sp. M42. Micromonospora sp. strain M42 was grown
in shake flasks and a 20 L fermenter in

2 liquid medium with vigorous aeration at 0˚C.

Ethyl acetate extracts from these cultures were screened by thin layer chromatography followed
by LC TOFMS for manzamine production. A similar method was used for production of 1-7
with 10 individual 1L cultures were prepared.
Extraction and Isolation. M42 was extracted with ethyl acetate at room temperature. The
extract was dried and subjected to silica gel vacuum-liquid chromatography and eluted beginning
with hexanes (100%), hexanes–acetone (9:1, 3:1, 1:1), acetone (100%), chloroform–methanol
(1:1) and finally with methanol (100%). Fraction 3, eluted with a gradient system of hexane–
acetone (3:1) was subjected to HPLC chromatography ( henomenex Luna
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μM 2 0 x 10.0 mm

column, flow rate 3 mL/min, λ 2 4, 60 nm) using a gradient solvent system of acetonitrile and
water both with 0.1% TFA to obtain MA and MB. For purification of compounds 1-7, each 1 L
culture of M42 was extracted on day four of fermentation by initially adding 75 mL of MeOH
followed by 3x partition with 150 ml chloroform. The organic layer was removed and dried to
afford 511 mg of a brown solid material. The material was subjected to a C18 flash cartridge
give four fractions eluting, respectively, with water (100%), water:methanol (1:1), methanol
(100%), and chloroform (100%). The water:methanol (1:1) fraction (67 mg of green/brown
solid) was then fractionated using HPLC employing a Phenomenex 250 x 10 mm Ultracarb
column with the following gradient: 1:4 acetonitrile:water (5 min isocratic) to 100% acetonitrile
(55 min linear gradient, 3 mL/min, λ 260 nm) to give 22 fractions. Fractions containing aromatic
1

H-NMR signals were further separated using HPLC with a Phenomenex 10 mm Luna amino

column employing a gradient of 100% hexanes to 100% dichloromethane (45 min linear
gradient, 3 mL/min, λ 260 nm) to give compounds 1-7.
Precursor Directed Biosynthetic Experiments. Commercially available tryptamine and ircinal
A isolated from the sponge were fed to M42. A 1L culture of M42 in ISP2 media supplemented
with 2% (wt/vol) aCl was shaken at 28˚C and 1 0 rpm for two days followed y addition of
tryptamine and ircinal A (each 25 mg). Cultures were further incubated for three days. Cells and
supernatant were separated by centrifugation. The supernatant was extracted with chloroform
and evaporated under vacuum. The crude extract was passed though SPE C8 column before
analysis using HPLC, LC TOF and NMR. These experiments were repeated four times yielding
a 5-fold increase in manzamine production.
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Figure III.14. 1H-NMR spectrum of 1 in CDCl3.

Figure III.15. 13C-NMR spectrum of 1 in CDCl3.
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Figure III.16. High resolution mass spectrum profile of 1 with the generated molecular formula.
The mass was measured using a Bruker Daltonics micrOTOF system.

Figure III.17. 1H-NMR spectrum of 2 in CDCl3.

64

Figure III.18. 13C-NMR spectrum of 2 in CDCl3.

Figure III.19. High resolution mass spectrum profile of 2 with the generated molecular formula.
The mass was measured using a Bruker Daltonics micrOTOF system.
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Figure III.20. 1H-NMR spectrum of 3 in CDCl3.

Figure III.21. 13C-NMR spectrum of 3 in CDCl3.
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Figure III.22. High resolution mass spectrum profile of 3 with the generated molecular formula.
The mass was measured using a Bruker Daltonics micrOTOF system.

Figure III.23. 1H-NMR spectrum of 4 in CDCl3.
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Figure III.24. 13C-NMR spectrum of 4 in CDCl3.
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Figure III.25. High resolution mass spectrum profile of 4 with the generated molecular formula
(3rd formula). The mass was measured using a Bruker Daltonics micrOTOF system.

Figure III.26. 1H-NMR spectrum of 5 in CDCl3.
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Figure III.27. High resolution mass spectrum profile of 5 with the generated molecular formula.
The mass was measured using a Bruker Daltonics micrOTOF system.

Figure III.28. 1H-NMR spectrum of 6 in CDCl3.
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Figure III.29. High resolution mass spectrum of 6 generated using Bruker Daltonics micrOTOF
system. The spectrum shows the dimer of 6 plus sodium ion. The formula for the molecular
weight of the dimer is shown.

Figure III.30. 1H-NMR spectrum of 7 in CDCl3.
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Figure III.31. Mass spectrum of 7 generated using Bruker Daltonics micrOTOF system.
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CHAPTER 4

EXPLORING SOURCES AND OPTIMIZING ISOLATION OF NICOTIANAMINE

INTRODUCTION
Nicotianamine (NA) is a metabolite found in all higher plants functioning as a metal
chelating compound in plant tissues, binding metal ions so they can be transferred throughout the
plant.104 Another possible role includes protecting plants from oxidative stress.105 Recent studies
have shown that NA possesses anti-hypertensive effects which are related to its ability to inhibit
the angiotensin I-converting enzyme (ACE) in the renin-angiotensin system.106 Pharmacological
ACE inhibitors are widely used for the control of high blood pressure, as well as in the treatment
of diabetic neuropathy and hypertensive related congestive heart failure. The ACE enzyme must
bind zinc in each present active site for catalytic activity, leading researchers to speculate that
NA inhibits ACE activity via zinc chelation. However, recent studies have shown that NA
demonstrates preferential inhibition towards ACE. NA has a similar inhibition rate as the known
metal chelator, EDTA, for the zinc-containing enzyme carboxypeptidase A.106 Interestingly, NA
has a 15 times higher inhibition rate for ACE than EDTA.106 This preferential mixed inhibition
indicates that NA could possibly have medicinal utility as an ACE inhibitor.
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NA has also displayed potential as a replacement for EDTA as a food additive to prevent
spoilage.107 Metal ions can act as catalysts for oxidative reactions that can cause spoilage in food
products. EDTA is a synthetic chelator that is currently added to many food products to
sequester metal ions and prevent oxidative reactions. Utilizing NA as a natural metal chelator
could allow companies to la el food products as “all-natural” while still controlling spoilage.
NA functions mainly as an iron chelator in plants, and previous reports have
demonstrated how NA possesses the optimal molecular structure for Fe(II) complex formation
(Figure IV.1). The particular location of the oxygen atoms on one side of the complex and the
methylene groups and/or the azetidine ring system on the other might play a significant role in
the biological function of the complex.

Figure IV.1. Model of the Fe(II)-NA complex.
Although all higher plants contain NA, graminaceous and non-graminaceous plants can
be differentiated based on NA use. Graminaceous plants use NA as a precursor in the
biosynthetic production of the mugineic acid family of phytosiderophores, while non-
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graminaceous plants do not utilize this pathway.104 The biosynthetic pathway that is utilized for
the production of NA is identical for both sets of plants and is shown in Figure IV.2. NA is
formed by the trimerization of three molecules of S-adenosyl methionine. Graminaceous plants
that thrive in iron deficient conditions show a higher degree of plasticity in regards to the NA
synthase gene.108 Another important distinction between plants with respect to NA production
relates to plants involved in metal hyperaccumulation. Thlaspi caerulescens can thrive in soil
with concentrations of nickel that would be toxic to other plants. More NA is produced and
resistance to high nickel soil concentrations is conferred when the NA synthase gene from T.
caerulescens is spliced into Arabidopsis thaliana.109

Figure IV.2. Biosynthetic pathway of nicotianamine
All of these considerations can be taken into account when deciding on source material
for NA extraction. Iron deficient conditions would only need to be utilized if the plant species is
both graminaceous and adaptive to iron deficient conditions. For example, if rice were chosen, it
would not be cost effective to transport plants to iron deficient soils for a certain time period
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before starting the extraction process. However, if barley were considered, this could potentially
be a vital step in increasing NA production.
Nicotianamine Sources
Because NA is found in many different commonly found plant species, an abundance of
available resources can be analyzed for the best possible NA yield. The goal is to use analytical
methods to efficiently screen a high number of different samples for NA content and further be
able to isolate and purify gram scale quantities. Soybean and soy products are likely to be a
reasonable starting point for the NA analysis based on patented processes.110 A number of
commercially available soy products as well as different hybrids of unprocessed soybean
material can be readily obtained from agricultural services in the greater Mississippi area such as
Monsanto and the USDA. Further accessible sources that have been cited for NA production
include tobacco,111 tomato, and beechnuts.112 A listing with reported yields of NA in different
plant species is presented in Table IV.1.111 Bioengineering approaches could possibly utilize NA
synthase genes from plants involved with metal hyperaccumulation where they are constitutively
expressed.113
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Table IV.1. Reported sources and yields of NA.
Species
Datura metel (perennial herb)
Lycium chinense (Wolfberry)
Solanum melongena (eggplant)
Lycopersicon esculentum
(tomato)
Nicotiana tabacum B. Y.
(tobacco)
N. glutinosa (tobacco)
N. rustica (tobacco)
N. arentsii (tobacco)
N. alata (tobacco)
N. debneyi (tobacco)
Zea mays (corn)
Rohdea japonica (flower)
Fagus silvatica (beechnuts)
Soybeans

Reported Yield of NA (μmol/g fr. Wt)
0.12
0.69
0.05
0.05
0.05
0.07
0.19
0.12
0.03
0.13
0.02
trace
Not reported
0.3 % aqueous extract of soybeans

From Table IV.1, it is apparent that a multitude of common agricultural products contain
NA. Lycium chinense, commonly known as the Chinese Wolfberry plant, is notably richer in NA
content. The berries of the Wolfberry plant are commercially available at extremely affordable
prices114 although the reported yield resides in the Wolfberry leaves which can also be
purchased.115 Aside from the most easily acquired soy sources, tobacco species stand as a strong
and reasonable source of NA. The reported yields from Table IV.1 in regards to the tobacco
species are derived from the leaves of the plant as well. Tobacco leaves can also be purchased
commercially and analyzed using our analytical methods.

DETECTION LIMITS OF NA
Quantification Optimization
Since NA is amphiprotic (Figure IV.3), it could be relatively unreliable to quantify under
neutral pH and standard conditions of MS. Figure IV.3 illustrates the amount of ionic species of
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NA present at varying pH. From the figure, we can make predictions on the intensity of the
ionization detection based on pH. Using these calculated values, methods using volatile buffers
can be employed for the best quantification and detection of NA. The quantity of compounds can
be determined by our LC-TOF system in both positive and negative ion settings for optimal
measurements.

pH
0.00
1.20
2.00
5.00
8.00
9.60
14.00

%(-3)
0.00
0.00
0.00
0.00
0.03
5.71
99.94

%(-2)
0.00
0.00
0.00
0.00
17.69
86.07
0.06

%(-1)
0.00
0.00
0.00
0.43
66.83
8.17
0.00

%neutral
0.00
0.87
12.32
98.99
15.46
0.05
0.00

%(+1)
0.42
32.25
72.36
0.58
0.00
0.00
0.00

%(+2)
7.89
38.59
13.72
0.00
0.00
0.00
0.00

%(+3)
91.69
28.29
1.59
0.00
0.00
0.00
0.00

Figure IV.3. Percent of ionic states present at different pH values for NA (MarvinSketch 5.6.0.0)
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Testing Quantification with Buffer Solutions
To determine methods for the best quantification of NA on our TOF system and to also
find the best conditions to generate a calibration curve, standard solutions of different
concentration of buffer were created and analyzed. Equal amounts of NA standard were
dissolved in water, 0.05% HCOOH, 0.05% HCOOH with 5mM HCO2-NH4+, 0.05% HCOOH
with 10 mM HCO2-NH4+, 5 mM HCO2-NH4+, 10 mM HCO2-NH4+, respectively. Samples were
analyzed on MS by flow injection (FIA) to determine the best condition for quantification. Both
positive and negative ion modes were considered. As a result, 10mM ammonium formate
solution gave the best intensity using negative mode (Fig. IV.4) (extracted ion at m/z 302, [MH]+), while H2O gave the best intensity on positive mode (Fig. IV.5) (extracted ion at m/z 304,
[M+H]+), while 0.05% formic acid gave significant intensity as well. When comparing the two
detection modes, the positive mode provides a higher response (Fig. IV.6).

Figure IV.4. FIA analysis of NA in negative mode.
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Figure IV.5. FIA analysis of NA in positive mode.

Figure IV.6. Comparison of positive and negative modes.
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Sample Preparation
Commercially available NA was used to determine the detection limits. NA was
dissolved in water to create a stock solution of 1 mg/mL. A 10 fold serial dilution of the stock
solution was performed to create multiple data points until the limit of detection was reached.

LCMS Analysis
All data were generated using LCMS with our Bruker Daltonics micrOTOF instrument in
conjunction with Agilent 1100 series HPLC. A calibration curve (Fig. IV.7) was generated for
nicotianamine detection. The retention time for NA was determined as 2.75 min on a C8 column
(4.6 mm×1 0 mm,

μm, henomenex Luna) using an isocratic system with water-methanol

(98:2).
The limit of detection (counted as S/N = 10) of NA on our instrument was 4.2 ng and can
be seen in Figure IV.7. The standard curve was y = 10.06x – 287.97 (R2 = 0.9966, n = 3), which
was linear over the range of 0.21-4.2 g/mL (Figure 4), the precision was calculated as shown in
Table IV.2. The exact mass of NA (304 m/z, [M+H]+) was extracted from the chromatogram for
precise quantification.
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Figure IV.7. LC trace of each data point and calibration curve of NA

Table IV.2. Calibration of NA using LC-MS (n=3).
Concentration (ng/mL)
210

420

1050

2100

4200

Area
1350
1195
1127
3579
3933
3524
9600
10565
10578
22021
24154
21284
39385
40431
43794

Average
1224

*RSD (%)
9.34

3679

6.03

10248

5.47

22486

6.63

41203

5.59

*RSD (%)=((std dev*100)/mean)

EXPLORING SOURCES
Because NA is ubiquitous among plant species, options for finding a viable source are
broad. After searching what is known about NA production and yields, soybeans and soybean
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products were chosen for the initial attempt to isolate significant amounts. The samples that have
been retrieved for analysis include whole commercially produced soybeans from five different
hybrid species of whole soybeans and soy flour. Using techniques mentioned previously,110
method development was completed for efficient isolation and quantification of NA.

Whole Soybean Analysis
A total of 1.785 kg of the commercially available Asgrow 4531 strain soybeans from
Monsanto-Asgrow brand markets in Leland, MS, were ground and prepared for extraction to
validate the method. The ground material was soaked in 8 L warm water (40C) for roughly 20
hours and subjected to sonication. The aqueous extract (6 L) was removed from the soybean
material by use of mesh wiring filtration. Using a 1M HCl solution, the pH of the resulting
aqueous extract was adjusted to 4.5 to precipitate proteins. Using centrifugation, the proteins
from the pellet were removed and the aqueous extract retained. A total of 5.5 L of supernatant
was recovered and subsequently concentrated to 2.25 L using rotary evaporation. Ethanol (2.25
L) was added to the concentrated aqueous extract in order to precipitate the NA-containing
material. The mixture was stirred and placed under refrigeration overnight to maximize
precipitation. The resulting mixture was centrifuged to separate the precipitate from the aqueous
extract. The precipitate was lyophilized and yielded 15 g of dry material. NA was detected in the
material by LCTOF-MS using the same method (1 mL/min 98:2 water-methanol isocratic) used
for the standard curve (Figure IV.8).
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Soy Flour Analysis
Soy flour was obtained from a 1.5 lb (680 g) bag of Hodgson Mill soy flour expiration
date 11/10/12, barcode: 0 71518 05039 9. Water (2.5 L) was added to each of two 2.8 L flasks
containing 200 g of soy flour and pH was adjusted to 9 using sodium hydroxide and set to stir
magnetically at 2 C. The flour was then filtered using wire mesh filtration, and the pH was
adjusted to 4.5. The aqueous extract was centrifuged, and the protein-containing pellet was
removed. Ethanol was added to the supernatant at a concentration of 80% of total volume. The
resulting solution was centrifuged, and the NA-containing pellet was removed. The material was
lyophilized to yield 12.4 g of dry material. NA was detected by LCTOF-MS (Figure IV.8).

Figure IV.8. LCTOF MS traces of the whole soybean precipitate, soy flour precipitate, and NA
standard. Each trace represents the extracted ion for 304.2 (m/z) of NA.
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Quantification
Using a fresh standard of NA, the relative amounts of NA in the two sources (whole soy
and soy flour) was determined in the precipitate mixtures. Solutions (1 mg/mL) of the
precipitated mixtures were prepared and 20 µL were injected into the LC-MS system for a total
of 20 µg of material on the column. NA standard solution (5 µL of a 10 µg/mL stock) was
injected for a total of 50 ng of pure NA on the column. The determination was calculated based
on the one spot calibration (y = 60.11x). The ionization intensity of the extracted m/z 304.2 ion
for NA is shown in Figure IV.8 for the whole soy precipitate, soy flour precipitate, and the NA
standard obtained from Kraft Foods Global. The integration intensity of extracted m/z 304.2 ion
for 20 µg soy flour precipitate, 20 µg whole soy precipitate, and 50 ng of pure NA standard was
621051, 228178, and 603387, respectively. The following equations give the percent
composition of NA in the precipitate mixtures:

[(50 ng pure NA * 621051) / (603387)] / (20000 ng crude precipitate) * 100% = 0.26% NA in
soy flour precipitate

[(50 ng pure NA * 228178) / (603387)] / (20000 ng crude precipitate) * 100% = 0.1% NA in
whole soy precipitate

The percent of NA in precipitated mixtures from this process from the reported patent
range from 0.3-0.5%,110 making soy flour near to the reported range. Using the percent mass
composition found, the amount of NA in the 12.4g of soy flour precipitate is 31.93 mg. The
percent yield from a total of 400 g soy flour was determined to be 0.008%. For the whole soy
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bean precipitate, calculation determined that the 15 g of precipitate mixture contains 14.18 mg.
The percent yield from a total of 1.785 kg was determined to be 0.0007%. Comparing the yields
and convenience in handling necessary to produce the NA containing mixture from the two
sources, soy flour is easily a more efficient choice for retrieving respectable quantities of NA. A
comparison of LC traces of 1 mg/mL solutions of both whole soybean and soy flour precipitate
against a 50 ng standard of NA is shown in Figure IV.10. Based on the quantification of 31.9 mg
of NA per 400 g of soy flour, 62.7 kg are necessary to recover 5 g of NA according to the
following equation:

(5 g NA)(400 g soy flour) / (0.0319 g NA) = 62.7 kg soy flour

Figure IV.10. LCTOF MS traces for 1 mg/mL solutions of whole soy precipitate (green), soy
flour precipitate (blue), and 50 ng NA standard (red).
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